序号 |
标题 |
次数 |
作者 |
发布时间 |
83566 |
3,6-二叠氮基-1,2,4,5-四嗪(DiAT) |
94 |
WYQ |
2024-11-28 |
83567 |
CAS:1027785-95-0 Ga-DOTA-NOC |
130 |
zyl |
2024-11-28 |
83568 |
DOTAGA-rhCCK-9 |
103 |
wyh |
2024-11-28 |
83569 |
DOTA-Dglu-(Glu)5-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2的结构组成 |
122 |
wyh |
2024-11-28 |
83570 |
polylysine-(Gd-DOTA)的介绍 |
134 |
zyl |
2024-11-28 |
83571 |
(R)-DOTAGA-(COOt-Bu)4 817562-90-6 (R)-DOTAGA-四叔丁酯 |
110 |
zcy |
2024-11-28 |
83572 |
Azido-mono-amide-DOTA(B-288) |
143 |
zyl |
2024-11-28 |
83573 |
DOTA-PEGn-Cys-VS;单分散PEG偶联螯合剂DOTA |
114 |
wyh |
2024-11-28 |
83574 |
3-羟基-5-取代芳基吡唑[3,4-e]并-1,2,3,4-四嗪衍生物 |
113 |
WYQ |
2024-11-28 |
83575 |
氨基羧酸盐大环NOTA (N(3)O(3)) |
171 |
kx |
2024-11-28 |
83576 |
3,6-二对氯苯基-1,4-二氢-S-四嗪-1,4-二对甲基苯砜基 |
94 |
WYQ |
2024-11-28 |
83577 |
CAS:437608-50-9 Lutathera |
166 |
zyl |
2024-11-28 |
83578 |
3,6-二丙基-N,N'-二甲苯基-1,2,4,5-四嗪-1,4-二甲酰胺 |
106 |
WYQ |
2024-11-28 |
83579 |
DOTA-PEGn-Cys-VS;单分散PEG偶联螯合剂DOTA |
85 |
wyh |
2024-11-28 |
83580 |
3,6-二胺基-1,2,4,5-四嗪(DAT) |
122 |
WYQ |
2024-11-28 |
83581 |
CAS:2057438-24-9 Dotatate tfa |
84 |
zyl |
2024-11-28 |
83582 |
3,6-二(对氯苄基)-s-四嗪 |
87 |
WYQ |
2024-11-28 |
83583 |
DOTA-cBR96 , DOTA偶联BR96单克隆抗体 |
115 |
kx |
2024-11-28 |
83584 |
p-NH2-Bn-DOTA-hu14.18K322A |
134 |
wyh |
2024-11-28 |
83585 |
3,6-二(对氯苯基)-s-四嗪 |
97 |
WYQ |
2024-11-28 |
83586 |
DOTA-tri(acid)-amido-PEG3-Bromoacetamide 定制 |
111 |
zcy |
2024-11-28 |
83587 |
CAS:306776-79-4 DOTAGA-tetra (t-Bu ester) |
115 |
zyl |
2024-11-28 |
83588 |
N,N'-二取代基-3,6-二取代苯基-1,4-二氢-S-四嗪-1,4-二甲酰胺类化合物 |
112 |
WYQ |
2024-11-28 |
83589 |
DOTA-ZHER2:2891-Affibody |
167 |
wyh |
2024-11-28 |
83590 |
CAS:872469-60-8 大环化合物 |
83 |
zyl |
2024-11-28 |
83591 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)共轭GnRH肽 |
86 |
kx |
2024-11-28 |
83592 |
3,6-二取代苯基-1,4-二氢-S-四嗪-1,4-二甲酸甲酯化合物 |
86 |
WYQ |
2024-11-28 |
83593 |
3-氧代-5-取代芳基异唑[3,4-e]并-1,2,3,4-四嗪衍生物 |
85 |
WYQ |
2024-11-28 |
83594 |
cas:619300-53-7 DOTA-NOC;DOTA-Nal3-octreotide |
92 |
zcy |
2024-11-28 |
83595 |
CAS:157599-02-5 1,4,7,10-四(氨基羰甲基)-1,4,7,10-四氮杂环十二烷 |
86 |
zyl |
2024-11-28 |
83596 |
DOTA-peptide-(GGGF)-m170的结构组成 |
151 |
wyh |
2024-11-28 |
83597 |
DOTA-3P-RGD ,双功能螯合剂DOTA偶联环肽RGD二聚体 |
207 |
kx |
2024-11-28 |
83598 |
CAS:913542-71-9 DOTA di(tBu)ester |
89 |
zyl |
2024-11-28 |
83599 |
cas: 1192362-32-5 DOTA-LM3 |
110 |
zcy |
2024-11-28 |
83600 |
DOPE-PEG-DOTA 磷脂-聚乙二醇-大环配体 |
81 |
zyl |
2024-11-28 |
83601 |
DOTA-GX1 , 大环螯合剂DOTA缀合GX1肽 |
94 |
kx |
2024-11-28 |
83602 |
甲氧基DOTA;MeO-DOTA |
235 |
wyh |
2024-11-28 |
83603 |
cas:865470-67-3 DOTA-Thiol |
119 |
zcy |
2024-11-28 |
83604 |
3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-烷基酮 |
91 |
WYQ |
2024-11-28 |
83605 |
DOTA-tris(acid)-amido-dPEG-TFP ester |
101 |
zyl |
2024-11-28 |
83606 |
DOTA-赖氨酸(DOTA-L) |
128 |
kx |
2024-11-28 |
83607 |
p-NH2-benzyl-NOTA; p-NH2-苄基-NOTA缀合物 |
91 |
wyh |
2024-11-28 |
83608 |
3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-甲酸酯 |
75 |
WYQ |
2024-11-28 |
83609 |
cas:1908409-18-6 DOTA Zoledronate DOTA唑来膦酸盐 |
84 |
zcy |
2024-11-28 |
83610 |
CAS:177943-88-3 DOTATATE |
86 |
zyl |
2024-11-28 |